Clinical trial for Prostate Cancer Metastatic Castration-Resistant
Official title External Beam and Radioligand Radiotherapy for mCRPC
ClinicalTrials.gov ID: NCT07354594
What this study is testing
- Who it's for
- People with metastatic prostate cancer that no longer responds to hormone therapy and have specific tumors visible on scans.
- What's involved
- Participants receive the standard drug treatment. Those in the new group also get focused radiation on specific spots that may not have received enough dose from the drug.
- Time commitment
- The study involves up to six cycles of drug treatment and additional radiation sessions, with regular scans to monitor progress.
- Phase 2: a mid-size study of how well it works
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults, men only
You may be able to join if
- Receiving 177Lu-PSMA for mCRPC
- ECOG 0-1
- Presence of a discernible metastatic burden suitable for EBRT
- Receiving bone protective therapy
You likely can't join if
- no exclusions
The study team makes the final eligibility decision.
Where it is enrolling
- Montreal, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Montreal, Quebec, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.